191 related articles for article (PubMed ID: 1712816)
1. Hydrocortisone inhibits rat basophilic leukemia cell mediator release induced by neutrophil-derived histamine releasing activity as well as by anti-IgE.
White MV; Igarashi Y; Lundgren JD; Shelhamer J; Kaliner M
J Immunol; 1991 Jul; 147(2):667-73. PubMed ID: 1712816
[TBL] [Abstract][Full Text] [Related]
2. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
Undem BJ; Peachell PT; Lichtenstein LM
J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
[TBL] [Abstract][Full Text] [Related]
3. Human neutrophil-derived histamine-releasing activity (HRA-N) causes the release of serotonin but not arachidonic acid metabolites from rat basophilic leukemia cells.
Igarashi Y; Lundgren JD; Doerfler ME; Shelhamer JH; Kaliner MA; White MV
J Allergy Clin Immunol; 1992 Jun; 89(6):1085-97. PubMed ID: 1376734
[TBL] [Abstract][Full Text] [Related]
4. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
5. Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells.
Heavey DJ; Ernst PB; Stevens RL; Befus AD; Bienenstock J; Austen KF
J Immunol; 1988 Mar; 140(6):1953-7. PubMed ID: 2450136
[TBL] [Abstract][Full Text] [Related]
6. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone inhibits receptor-activated phosphoinositide breakdown in rat basophilic leukemia (RBL-2H3) cells.
Berenstein EH; Garcia-Gil M; Siraganian RP
J Immunol; 1987 Mar; 138(6):1914-8. PubMed ID: 2434566
[TBL] [Abstract][Full Text] [Related]
8. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release.
Holgate ST; Burns GB; Robinson C; Church MK
J Immunol; 1984 Oct; 133(4):2138-44. PubMed ID: 6206153
[TBL] [Abstract][Full Text] [Related]
9. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2.
Levi-Schaffer F; Dayton ET; Austen KF; Hein A; Caulfield JP; Gravallese PM; Liu FT; Stevens RL
J Immunol; 1987 Nov; 139(10):3431-41. PubMed ID: 2445814
[TBL] [Abstract][Full Text] [Related]
10. An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells.
Razin E; Romeo LC; Krilis S; Liu FT; Lewis RA; Corey EJ; Austen KF
J Immunol; 1984 Aug; 133(2):938-45. PubMed ID: 6330206
[TBL] [Abstract][Full Text] [Related]
11. Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE.
Ferreri NR; Howland WC; Spiegelberg HL
J Immunol; 1986 Jun; 136(11):4188-93. PubMed ID: 3009617
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of immunoglobulin, but not polypeptide base-stimulated release of histamine and arachidonic acid by anti-inflammatory steroids.
Heiman AS; Crews FT
J Pharmacol Exp Ther; 1984 Jul; 230(1):175-82. PubMed ID: 6205135
[TBL] [Abstract][Full Text] [Related]
13. Co-culture of human lung-derived mast cells with mouse 3T3 fibroblasts: morphology and IgE-mediated release of histamine, prostaglandin D2, and leukotrienes.
Levi-Schaffer F; Austen KF; Caulfield JP; Hein A; Gravallese PM; Stevens RL
J Immunol; 1987 Jul; 139(2):494-500. PubMed ID: 2439587
[TBL] [Abstract][Full Text] [Related]
14. Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells.
Katz HR; Raizman MB; Gartner CS; Scott HC; Benson AC; Austen KF
J Immunol; 1992 Feb; 148(3):868-71. PubMed ID: 1309842
[TBL] [Abstract][Full Text] [Related]
15. Effects of inhibitors of arachidonic acid metabolism on serotonin release from rat basophilic leukemia cells.
Igarashi Y; Lundgren JD; Shelhamer JH; Kaliner MA; White MV
Immunopharmacology; 1993; 25(2):131-44. PubMed ID: 8500985
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of IgE-mediated histamine release from rat basophilic leukemia cells and rat mast cells by inhibitors of transmethylation.
Morita Y; Siraganian RP
J Immunol; 1981 Oct; 127(4):1339-44. PubMed ID: 6168684
[TBL] [Abstract][Full Text] [Related]
17. Characterization of primate bronchoalveolar mast cells. II. Inhibition of histamine, LTC4, and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells.
Wells E; Jackson CG; Harper ST; Mann J; Eady RP
J Immunol; 1986 Dec; 137(12):3941-5. PubMed ID: 2431049
[TBL] [Abstract][Full Text] [Related]
18. Comparison of anti-allergic activities of the histamine H1 receptor antagonists epinastine, ketotifen and oxatomide in human leukocytes.
Mita H; Shida T
Arzneimittelforschung; 1995 Jan; 45(1):36-40. PubMed ID: 7893266
[TBL] [Abstract][Full Text] [Related]
19. Neutrophils and mast cells. I. Human neutrophil-derived histamine-releasing activity.
White MV; Kaliner MA
J Immunol; 1987 Sep; 139(5):1624-30. PubMed ID: 2442251
[TBL] [Abstract][Full Text] [Related]
20. Source of the arachidonic acid released on stimulation of rat basophilic leukemia cells.
Garcia-Gil M; Siraganian RP
J Immunol; 1986 May; 136(10):3825-8. PubMed ID: 2422263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
